Daniel Shu, Pharm D
About Daniel Shu, Pharm D
Daniel Shu, Pharm D, serves as the Senior Director of Global Regulatory Affairs at Kite Pharma, where he leads regulatory strategies for early phase oncology products and is the Global Regulatory Lead for Yescarta, a CAR T-cell therapy.
Work at Kite Pharma
Daniel Shu currently serves as the Senior Director of Global Regulatory Affairs at Kite Pharma, a position he has held since 2023. In this role, he leads global regulatory strategies for early phase oncology products and serves as the Global Regulatory Lead for Yescarta, a CAR T-cell therapy. His responsibilities include overseeing regulatory submissions and ensuring compliance with global regulations.
Previous Experience in Regulatory Affairs
Before joining Kite Pharma, Daniel Shu held various roles at AstraZeneca. He worked as Associate Director of Regulatory Affairs in Oncology for three months in 2020 and served as Director of Regulatory Affairs, Oncology from 2020 to 2021. Additionally, he was a Postdoctoral Fellow in Global Regulatory Affairs, Oncology from 2016 to 2018, and a Manager in Regulatory Affairs, Oncology from 2018 to 2020. His experience at AstraZeneca contributed to his expertise in oncology regulatory strategies.
Education and Expertise
Daniel Shu earned his Doctor of Pharmacy degree from the University of Maryland School of Pharmacy, where he studied from 2012 to 2016. He also holds a Bachelor of Science in Biology from the University of Maryland Baltimore County, completed from 2008 to 2012. His educational background provides a strong foundation for his work in regulatory affairs, particularly in oncology.
Internships and Early Career
Daniel Shu began his career with several internships that provided him with valuable experience in the pharmaceutical industry. He worked as an Analytical Development Intern at Teva Pharmaceuticals in 2013 and as a Global Marketing Intern at NASDAQ from 2012 to 2013. He also completed externships at the FDA and Procter & Gamble in 2016, focusing on clinical outcomes assessment and medical affairs, respectively.
Teaching Experience
From 2016 to 2018, Daniel Shu served as Adjunct Faculty at Rutgers University. In this role, he contributed to the education of pharmacy students, sharing his knowledge and experience in the field of pharmacy and regulatory affairs. This position reflects his commitment to advancing the profession through education.